Marshall Wace’s CONMED CNMD Stock Holding History
Bought
Maintained
Sold
Other funds holding CNMD
VPM
VCM
CB
Marshall Wace's CNMD Position: Q1 2026 in Review
Marshall Wace reduced its CONMED (CNMD) stake by 23% in Q1 2026, selling an estimated $2.1M and leaving 170,756 shares worth $6.04M. The position accounts for 0.01% of the portfolio, ranked #1210.
Marshall Wace first reported a position in CNMD in Q2 2014 and has held it in 16 quarters since. The position peaked at $33.2M in Q1 2019. 236 funds tracked by Wall St. Rank hold CNMD as of Q1 2026.
- Marshall Wace held 170,756 shares of CONMED worth $6.04M as of Q1 2026.
- Marshall Wace sold 51,630 CONMED shares in Q1 2026, an estimated $2.1M.
- CONMED made up 0.01% of Marshall Wace's portfolio in Q1 2026, its #1210 holding.
- Marshall Wace first reported a position in CONMED in Q2 2014 and has held it in 16 quarters since.
- Marshall Wace's CONMED position peaked at $33.2M in Q1 2019.
- 236 funds tracked by Wall St. Rank held CONMED as of Q1 2026.
Based on Marshall Wace's 13F filing for Q1 2026, filed 15 May 2026.